PL310699A1 - Molecule specifically bonding itself with antigen determinant of escape mutation of hepatitis b - Google Patents

Molecule specifically bonding itself with antigen determinant of escape mutation of hepatitis b

Info

Publication number
PL310699A1
PL310699A1 PL94310699A PL31069994A PL310699A1 PL 310699 A1 PL310699 A1 PL 310699A1 PL 94310699 A PL94310699 A PL 94310699A PL 31069994 A PL31069994 A PL 31069994A PL 310699 A1 PL310699 A1 PL 310699A1
Authority
PL
Poland
Prior art keywords
hepatitis
molecule specifically
antigen determinant
bonding itself
escape mutation
Prior art date
Application number
PL94310699A
Inventor
Jennifer Anne Waters
William Frederick Carman
Howard Christopher Thomas
Original Assignee
Imperial College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939306087A external-priority patent/GB9306087D0/en
Priority claimed from GB939311526A external-priority patent/GB9311526D0/en
Application filed by Imperial College filed Critical Imperial College
Publication of PL310699A1 publication Critical patent/PL310699A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL94310699A 1993-03-24 1994-03-24 Molecule specifically bonding itself with antigen determinant of escape mutation of hepatitis b PL310699A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306087A GB9306087D0 (en) 1993-03-24 1993-03-24 Specific binding molecules and their uses
GB939311526A GB9311526D0 (en) 1993-06-04 1993-06-04 Specific binding molecules and their uses

Publications (1)

Publication Number Publication Date
PL310699A1 true PL310699A1 (en) 1995-12-27

Family

ID=26302640

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94310699A PL310699A1 (en) 1993-03-24 1994-03-24 Molecule specifically bonding itself with antigen determinant of escape mutation of hepatitis b

Country Status (9)

Country Link
EP (1) EP0689605A1 (en)
JP (1) JPH08510635A (en)
CN (1) CN1121357A (en)
AU (1) AU681636B2 (en)
CA (1) CA2158866A1 (en)
NO (1) NO953749L (en)
NZ (1) NZ262929A (en)
PL (1) PL310699A1 (en)
WO (1) WO1994021812A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608626D0 (en) * 1996-04-25 1996-07-03 Univ College Of London Hepatitis b monoclonal antibodies
EP0919568A1 (en) 1997-12-01 1999-06-02 Sorin Diagnostics S.r.l. Escape mutant of the surface antigen of hepatitis B virus
AUPP967999A0 (en) 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
ES2488849T3 (en) * 2004-06-07 2014-08-29 Novartis Vaccines And Diagnostics, Inc. Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of use thereof
JP4430677B2 (en) * 2004-09-22 2010-03-10 株式会社先端生命科学研究所 Method for detecting hepatitis B virus s antigen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine

Also Published As

Publication number Publication date
CN1121357A (en) 1996-04-24
AU6287094A (en) 1994-10-11
JPH08510635A (en) 1996-11-12
NO953749L (en) 1995-11-22
CA2158866A1 (en) 1994-09-29
WO1994021812A2 (en) 1994-09-29
AU681636B2 (en) 1997-09-04
EP0689605A1 (en) 1996-01-03
WO1994021812A3 (en) 1994-11-10
NO953749D0 (en) 1995-09-22
NZ262929A (en) 1997-08-22

Similar Documents

Publication Publication Date Title
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
HU9601574D0 (en) Humanized antibodies and uses thereof
HUP0100794A3 (en) Novel method for the production of anti-human antigen receptors and uses thereof
EP0480188A3 (en) Sealing materials and glasses
GB9009549D0 (en) Recombinant antibody and method
IL109445A0 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
PL310699A1 (en) Molecule specifically bonding itself with antigen determinant of escape mutation of hepatitis b
EP0469897A3 (en) Engineered antibodies
GB9420014D0 (en) Improvements in the manufacture of glass containers
EP0705796A3 (en) Improvements in the manufacture of glass containers
HU9501328D0 (en) Production of human monoclonal antibodies active against hepatitis b surface antigen
SG48325A1 (en) Cloning and expression of a protein antigen of toxoplasma gondii
ZA945696B (en) Novel Eimeria antibodies and antigens and methods of using the same
ZA947564B (en) Production of antigens
EP0637631A3 (en) Highly efficient expression of a polypeptide containing a modified preS1 region of the major hepatitis B virus antigen.
GB9400356D0 (en) Top drive cementing manifold
ZA94740B (en) Expression of pretective antigens
AUPM296493A0 (en) Immunoreactive antigens of hepatitis e virus - II
IL94304A0 (en) Novel tumor-associated antigen,antibodies,compositions and uses therefor
ITFI920071A1 (en) PROTEIN RECOMBINANT ANTIGENS WITH INCREASED IMMUNOGENICITY CONTAINING THE PEPTIDE REPRESENTED BY THE VQGEESNDK SEQUENCE
AU6769594A (en) Hepatitis c virus immunodiagnostic antigens and antibodies
AU6991098A (en) Immunoreactive antigens of hepatitis E virus
ZA932210B (en) A process for preparation of a recombinant hepatitis B surface antigen, and antigen and vaccine based thereon
GB9106568D0 (en) Recombinant antigen
PL314469A1 (en) Production of human monoclonal antibodies against surface antigene of b hepatitis